Wells Fargo & Company MN trimmed its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 52.2% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 150,453 shares of the medical instruments supplier's stock after selling 164,585 shares during the quarter. Wells Fargo & Company MN owned 0.08% of DENTSPLY SIRONA worth $2,856,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Nordea Investment Management AB lifted its holdings in DENTSPLY SIRONA by 245.0% in the 4th quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier's stock valued at $4,754,000 after acquiring an additional 178,639 shares during the last quarter. JPMorgan Chase & Co. increased its position in shares of DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock worth $49,990,000 after acquiring an additional 1,244,326 shares in the last quarter. Bank of New York Mellon Corp raised its holdings in shares of DENTSPLY SIRONA by 27.9% during the fourth quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier's stock valued at $45,611,000 after acquiring an additional 523,692 shares during the period. Charles Schwab Investment Management Inc. lifted its position in shares of DENTSPLY SIRONA by 1.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier's stock valued at $39,880,000 after acquiring an additional 35,360 shares in the last quarter. Finally, Barclays PLC lifted its position in shares of DENTSPLY SIRONA by 21.8% in the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock valued at $8,301,000 after acquiring an additional 54,920 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several brokerages have issued reports on XRAY. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. Morgan Stanley downgraded DENTSPLY SIRONA from an "overweight" rating to an "equal weight" rating and set a $14.00 price objective for the company. in a research note on Tuesday, April 15th. Jefferies Financial Group cut DENTSPLY SIRONA from a "buy" rating to a "hold" rating and lowered their target price for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. StockNews.com downgraded DENTSPLY SIRONA from a "buy" rating to a "hold" rating in a report on Friday, February 28th. Finally, Wells Fargo & Company dropped their target price on DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating on the stock in a report on Friday, February 28th. Thirteen investment analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Hold" and a consensus price target of $22.58.
View Our Latest Analysis on DENTSPLY SIRONA
DENTSPLY SIRONA Stock Performance
DENTSPLY SIRONA stock traded up $0.08 during trading hours on Tuesday, reaching $13.95. 2,445,812 shares of the company were exchanged, compared to its average volume of 2,971,166. The firm has a market cap of $2.78 billion, a price-to-earnings ratio of -6.74, a PEG ratio of 1.80 and a beta of 0.92. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The stock has a 50-day moving average of $14.89 and a 200 day moving average of $18.14. DENTSPLY SIRONA Inc. has a 12 month low of $12.16 and a 12 month high of $30.78.
DENTSPLY SIRONA Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were given a dividend of $0.16 per share. The ex-dividend date of this dividend was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 4.59%. DENTSPLY SIRONA's payout ratio is currently -14.07%.
Insiders Place Their Bets
In related news, Director Gregory T. Lucier bought 15,142 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was purchased at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the transaction, the director now directly owns 81,971 shares of the company's stock, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.52% of the company's stock.
DENTSPLY SIRONA Company Profile
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Further Reading

Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.